Trius Therapeutics Inc - FORM S-1/A - EX-23.1 - CONSENT OF ERNST & YOUNG LLP - February 10, 2010

Attached files

file filename
S-1/A - AMENDMENT NO.3 TO FORM S-1 - Trius Therapeutics Incds1a.htm
EX-10.1 - FORM OF INDEMNITY AGREEMENT - Trius Therapeutics Incdex101.htm
EX-4.1 - FORM OF COMMON STOCK CERTIFICATE - Trius Therapeutics Incdex41.htm
EX-10.5 - 2010 EMPLOYEE STOCK PURCHASE PLAN - Trius Therapeutics Incdex105.htm
EX-10.4 - 2010 NON-EMPLOYEE DIRECTOR'S STOCK OPTION PLAN - Trius Therapeutics Incdex104.htm
EX-10.3 - 2010 EQUITY INCENTIVE PLAN - Trius Therapeutics Incdex103.htm
EX-10.2 - AMENDED AND RESTATED 2006 EQUITY INCENTIVE PLAN - Trius Therapeutics Incdex102.htm

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the reference to our firm under the caption “Experts” and to the use of our report dated February 10, 2010 (except Note 12, as to which the date is February     , 2010) in Amendment No. 3 to the Registration Statement (Form S-1 No. 333-162945) and related Prospectus of Trius Therapeutics, Inc. for the registration of shares of its common stock.

 

Ernst & Young LLP

San Diego, California

February     , 2010

 

 

The foregoing consent is in the form that will be signed upon completion of the 1 for 8.6 reverse stock split of the common stock of the Company described in Note 12 to the financial statements.

 

/s/ Ernst & Young LLP

San Diego, California

February 10, 2010

Trius Therapeutics Inc Reports

Also read